{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:54:16Z","timestamp":1773096856772,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1013467","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000}}],"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MC_PC_19084"],"award-info":[{"award-number":["MC_PC_19084"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["225001\/Z\/22\/Z"],"award-info":[{"award-number":["225001\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health","award":["1R01AI141534-01A1"],"award-info":[{"award-number":["1R01AI141534-01A1"]}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["226142\/Z\/22\/Z"],"award-info":[{"award-number":["226142\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    Understanding acute infectious disease dynamics at individual and population levels is critical for informing public health preparedness and response. Serological assays, which measure a range of biomarkers relating to humoral immunity, can provide a valuable window into immune responses generated by past infections and vaccinations. However, traditional methods for interpreting serological data, such as binary seropositivity and seroconversion thresholds, often rely on heuristics that fail to account for individual variability in antibody kinetics and timing of infection, potentially leading to biased estimates of infection rates and post-exposure immune responses. To address these limitations, we developed\n                    <jats:italic>\n                      <jats:italic>serojump<\/jats:italic>\n                    <\/jats:italic>\n                    , a novel probabilistic framework and software package that uses individual-level serological data to infer infection status, timing, and subsequent antibody kinetics. We validated\n                    <jats:italic>\n                      <jats:italic>serojump<\/jats:italic>\n                    <\/jats:italic>\n                    using simulated serological data and real-world SARS-CoV-2 datasets from The Gambia. In simulation studies, the model accurately recovered individual infection status, population-level antibody kinetics, and the relationship between biomarkers and immunity against infection, demonstrating robustness under observational noise. Benchmarking against standard serological heuristics in real-world data revealed that\n                    <jats:italic>\n                      <jats:italic>serojump<\/jats:italic>\n                    <\/jats:italic>\n                    achieves higher sensitivity in identifying infections, outperforming static threshold-based methods and precision in inferred infection timing. Application of\n                    <jats:italic>\n                      <jats:italic>serojump<\/jats:italic>\n                    <\/jats:italic>\n                    to longitudinal SARS-CoV-2 serological data taken during the Delta wave provided additional insights into i) missed infections based on sub-threshold rises in antibody level and ii) antibody responses to multiple biomarkers post-vaccination and infection. Our findings highlight the utility of\n                    <jats:italic>\n                      <jats:italic>serojump<\/jats:italic>\n                    <\/jats:italic>\n                    as a pathogen-agnostic, flexible tool for serological inference, enabling deeper insights into infection dynamics, immune responses, and correlates of protection. The open-source framework offers researchers a platform for extracting information from serological datasets, with potential applications across various infectious diseases and study designs.\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1013467","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T18:03:17Z","timestamp":1757354597000},"page":"e1013467","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["serojump: A Bayesian tool for inferring infection timing and antibody kinetics from longitudinal serological data"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5585-8974","authenticated-orcid":true,"given":"David","family":"Hodgson","sequence":"first","affiliation":[]},{"given":"James","family":"Hay","sequence":"additional","affiliation":[]},{"given":"Sheikh","family":"Jarju","sequence":"additional","affiliation":[]},{"given":"Dawda","family":"Jobe","sequence":"additional","affiliation":[]},{"given":"Rhys","family":"Wenlock","sequence":"additional","affiliation":[]},{"given":"Thushan I.","family":"de Silva","sequence":"additional","affiliation":[]},{"given":"Adam J.","family":"Kucharski","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"issue":"9","key":"pcbi.1013467.ref001","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/tmi.12737","article-title":"Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries","volume":"21","author":"FT Cutts","year":"2016","journal-title":"Trop Med Int Health"},{"issue":"100806","key":"pcbi.1013467.ref002","doi-asserted-by":"crossref","first-page":"100806","DOI":"10.1016\/j.epidem.2024.100806","article-title":"Serodynamics: A primer and synthetic review of methods for epidemiological inference using serological data","volume":"49","author":"JA Hay","year":"2024","journal-title":"Epidemics"},{"issue":"7","key":"pcbi.1013467.ref003","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3390\/pathogens11070732","article-title":"Serology as a Tool to Assess Infectious Disease Landscapes and Guide Public Health Policy","volume":"11","author":"AH Haselbeck","year":"2022","journal-title":"Pathogens"},{"issue":"1","key":"pcbi.1013467.ref004","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12916-021-01982-x","article-title":"Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections","volume":"19","author":"SAFER Investigators and Field Study Team, Crick COVID-19 Consortium, CMMID COVID-19 working group,","year":"2021","journal-title":"BMC Med"},{"issue":"3","key":"pcbi.1013467.ref005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1086\/505400","article-title":"A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis","volume":"43","author":"DH Crawford","year":"2006","journal-title":"Clin Infect Dis"},{"key":"pcbi.1013467.ref006","doi-asserted-by":"crossref","first-page":"101033","DOI":"10.1016\/j.eclinm.2021.101033","article-title":"Risk Factors for HIV sero-conversion in a high incidence cohort of men who have sex with men and transgender women in Bangkok, Thailand","volume":"38","author":"T Wansom","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"3","key":"pcbi.1013467.ref007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005475","article-title":"Dengue seroprevalence, seroconversion and risk factors in Dhaka, Bangladesh","volume":"11","author":"P Dhar-Chowdhury","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pcbi.1013467.ref008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009457","article-title":"Determining seropositivity-A review of approaches to define population seroprevalence when using multiplex bead assays to assess burden of tropical diseases","volume":"15","author":"Y Chan","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"pcbi.1013467.ref009","doi-asserted-by":"crossref","DOI":"10.1017\/S095026882300122X","article-title":"Seroprevalence of Toxoplasma gondii and associated risk factors for infection in the Netherlands: third cross-sectional national study","volume":"151","author":"OE van den Berg","year":"2023","journal-title":"Epidemiol Infect"},{"key":"pcbi.1013467.ref010","doi-asserted-by":"crossref","first-page":"220","DOI":"10.12688\/wellcomeopenres.17143.3","article-title":"Risk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust","volume":"6","author":"H Colton","year":"2022","journal-title":"Wellcome Open Res"},{"issue":"2","key":"pcbi.1013467.ref011","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/irv.12805","article-title":"Incidence of influenza virus infections confirmed by serology in children and adult in a suburb community, northern China, 2018-2019 influenza season","volume":"15","author":"C Xu","year":"2021","journal-title":"Influenza Other Respir Viruses"},{"issue":"12","key":"pcbi.1013467.ref012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003061","article-title":"Influenza infection rates, measurement errors and the interpretation of paired serology","volume":"8","author":"S Cauchemez","year":"2012","journal-title":"PLoS Pathog"},{"issue":"5","key":"pcbi.1013467.ref013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004882","article-title":"Estimating Time of Infection Using Prior Serological and Individual Information Can Greatly Improve Incidence Estimation of Human and Wildlife Infections","volume":"12","author":"B Borremans","year":"2016","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"pcbi.1013467.ref014","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/ele.12732","article-title":"Inferring infection hazard in wildlife populations by linking data across individual and population scales","volume":"20","author":"KM Pepin","year":"2017","journal-title":"Ecol Lett"},{"issue":"7707","key":"pcbi.1013467.ref015","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41586-018-0157-4","article-title":"Reconstruction of antibody dynamics and infection histories to evaluate dengue risk","volume":"557","author":"H Salje","year":"2018","journal-title":"Nature"},{"issue":"1","key":"pcbi.1013467.ref016","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41467-022-29310-8","article-title":"Reconstructing antibody dynamics to estimate the risk of influenza virus infection","volume":"13","author":"TK Tsang","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"pcbi.1013467.ref017","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/biomet\/82.4.711","article-title":"Reversible jump Markov chain Monte Carlo computation and Bayesian model determination","volume":"82","author":"PJ Green","year":"1995","journal-title":"Biometrika"},{"issue":"2","key":"pcbi.1013467.ref018","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/1467-9876.00061","article-title":"Markov Chain Monte Carlo Methods for Fitting Spatiotemporal Stochastic Models in Plant Epidemiology","volume":"46","author":"GJ Gibson","year":"1997","journal-title":"Journal of the Royal Statistical Society Series C: Applied Statistics"},{"key":"pcbi.1013467.ref019","author":"H Lyyjynen","year":"2014","journal-title":"Reversible Jump Markov Chain Monte Carlo: Some Theory and Applications [Master\u2019s Thesis]."},{"issue":"1","key":"pcbi.1013467.ref020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11222-006-5338-6","article-title":"Multivariate mixtures of normals with unknown number of components","volume":"16","author":"P Dellaportas","year":"2006","journal-title":"Stat Comput"},{"issue":"16","key":"pcbi.1013467.ref021","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.3390\/app11167343","article-title":"On the Reversible Jump Markov Chain Monte Carlo (RJMCMC) Algorithm for Extreme Value Mixture Distribution as a Location-Scale Transformation of the Weibull Distribution","volume":"11","author":"Irhamah","year":"2021","journal-title":"Applied Sciences"},{"issue":"4","key":"pcbi.1013467.ref022","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/1467-9868.00095","article-title":"On Bayesian analysis of mixtures with an unknown number of components","volume":"59","author":"S Richardson","year":"1997","journal-title":"J R Stat Soc B"},{"issue":"3","key":"pcbi.1013467.ref023","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1467-9574.2012.00516.x","article-title":"Model choice using reversible jump Markov chain Monte Carlo","volume":"66","author":"DI Hastie","year":"2012","journal-title":"Statistica Neerlandica"},{"issue":"8","key":"pcbi.1013467.ref024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011384","article-title":"serosim: An R package for simulating serological data arising from vaccination, epidemiological and antibody kinetics processes","volume":"19","author":"A Menezes","year":"2023","journal-title":"PLoS Comput Biol"},{"issue":"5","key":"pcbi.1013467.ref025","article-title":"An open source tool to infer epidemiological and immunological dynamics from serological data: serosolver","volume":"16","author":"JA Hay","year":"2020","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"pcbi.1013467.ref026","first-page":"767","article-title":"The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses","volume":"70","author":"D Hobson","year":"1972","journal-title":"J Hyg (Lond)"},{"issue":"7","key":"pcbi.1013467.ref027","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"DS Khoury","year":"2021","journal-title":"Nat Med"},{"issue":"3","key":"pcbi.1013467.ref028","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.01.017","article-title":"SARS-CoV-2-infection- and vaccine-induced antibody responses are long lasting with an initial waning phase followed by a stabilization phase","volume":"57","author":"K Srivastava","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"pcbi.1013467.ref029","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1038\/s41467-024-48098-3","article-title":"High SARS-CoV-2 incidence and asymptomatic fraction during Delta and Omicron BA.1 waves in The Gambia","volume":"15","author":"S Jarju","year":"2024","journal-title":"Nat Commun"},{"key":"pcbi.1013467.ref030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.epidem.2016.04.001","article-title":"Linking the seroresponse to infection to within-host heterogeneity in antibody production","volume":"16","author":"PFM Teunis","year":"2016","journal-title":"Epidemics"},{"key":"pcbi.1013467.ref031","doi-asserted-by":"crossref","unstructured":"Nilles EJ, Roberts K, Aubin M de S, Mayfield H, Restrepo AC, Garnier S, et al. Convergence of SARS-CoV-2 spike antibody levels to a population immune setpoint. eBioMedicine [Internet]. 2024 Oct 1 [cited 2025 Jul 3];108. Available from: https:\/\/www.thelancet.com\/journals\/ebiom\/article\/PIIS2352-3964%2824%2900355-4\/fulltext?utm_source=chatgpt.com","DOI":"10.1016\/j.ebiom.2024.105319"},{"key":"pcbi.1013467.ref032","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. 2016; Available from: http:\/\/www.r-project.org\/"},{"key":"pcbi.1013467.ref033","unstructured":"Seamless R and C++ Integration [R package Rcpp version 1.0.14]. 2025 Jan 12 [cited 2025 Mar 4]; Available from: https:\/\/CRAN.R-project.org\/package=Rcpp"},{"issue":"5","key":"pcbi.1013467.ref034","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11004-019-09811-x","article-title":"Convergence Tests for Transdimensional Markov Chains in Geoscience Imaging","volume":"52","author":"M Somogyv\u00e1ri","year":"2019","journal-title":"Math Geosci"},{"issue":"2","key":"pcbi.1013467.ref035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11004-017-9709-7","article-title":"Estimation of the Continuous Ranked Probability Score with Limited Information and Applications to Ensemble Weather Forecasts","volume":"50","author":"M Zamo","year":"2017","journal-title":"Math Geosci"},{"issue":"6","key":"pcbi.1013467.ref036","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/microorganisms9061340","article-title":"Confounding Factors Influencing the Kinetics and Magnitude of Serological Response Following Administration of BNT162b2","volume":"9","author":"J-L Bayart","year":"2021","journal-title":"Microorganisms"},{"issue":"8","key":"pcbi.1013467.ref037","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3390\/vaccines10081169","article-title":"Antibodies to NCP, RBD and S2 SARS-CoV-2 in Vaccinated and Unvaccinated Healthcare Workers","volume":"10","author":"A B\u0142aszczuk","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"pcbi.1013467.ref038","unstructured":"nathoze. nathoze\/Rsero [Internet]. 2025 [cited 2025 Jul 3]. Available from: https:\/\/github.com\/nathoze\/Rsero"},{"key":"pcbi.1013467.ref039","volume-title":"serofoi: Bayesian Estimation of the Force of Infection from Serological Data [Internet]","author":"ZM Cucunub\u00e1","year":"2025"},{"issue":"7","key":"pcbi.1013467.ref040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002802","article-title":"Evidence for antigenic seniority in influenza A (H3N2) antibody responses in southern China","volume":"8","author":"J Lessler","year":"2012","journal-title":"PLoS Pathog"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1013467","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1013467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T17:50:01Z","timestamp":1758563401000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1013467"}},"subtitle":[],"editor":[{"given":"Simon","family":"Cauchemez","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1013467","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.04.25323335","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]}}}